Clinically Relevant Pancreatic Fistula After Pancreaticoduodenectomy
Clinically Relevant Postoperative Pancreatic Fistula After Pancreaticoduodenectomy for Periampullary Cancer and Risk Factors: A Prospective Multicenter Study
1 other identifier
observational
183
1 country
1
Brief Summary
Patients who are diagnosed with periampullary cancer will be performed pancreaticoduodenectomy with 3 types of pancreatic-jejunal anastomosis reconstructions. The investigator will analysis the complication of pancreatic fistula about: the clinical symptoms, laboratory test changing, intra-operative morphology, the risk factors
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2021
CompletedFirst Submitted
Initial submission to the registry
August 6, 2021
CompletedFirst Posted
Study publicly available on registry
August 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2023
CompletedMay 17, 2024
May 1, 2024
2.2 years
August 6, 2021
May 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Pancreatic fistula
The investigator will describe the day that appears pancreatic fistula, the clinical symptoms, intra-operative morphology if being indicated to re-operate. The measurement tool to diagnose pancreatic fistula is fluid amylase on the POD3 (fluid amylse is 3 times compared to serum's amylase)
30 days of post-operative period
Risk factors relate to pancreatic fistula
The investigator will analyse some of the risk factors that relate to pancreatic fistula, including pre-operative factors (BMI, albumin, bilirubin, biliary drainage), intra-operative elements (pancreatic duct 's diameter, pancreatic textile, blood transfusion, portal vein reconstruction), and post-operative factors (abdominal drainage's volume, fluid amylase, abdominal abscess..). The investigator will use the multivariable regression model to determine the risk factors (p-value\<0.05)
30 days of post-operative period
Secondary Outcomes (1)
Short-term result in treatment of post-operative pancreatic fistula
30 days of post-operatvive period
Study Arms (1)
Patient with periampullary cancer and pancreaticoduodenectomy
Only one group of patient with periampullary cancer
Interventions
Pancreaticoduodenectomy with one of 2 types of pancreaticojejunal anastomosis: Blumgart and conventional duct-to-mucosa
Eligibility Criteria
Periampullary cancer with postoperative pathology is adenocarcinoma
You may qualify if:
- Patient with periampullary cancer and can be performed pancreaticoduodenectomy.
- Pancreaticoduodenectomy with one of three types of pancreatic - duodenal anastomosis reconstructions.
You may not qualify if:
- The patient does not consent to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vo Truong Quoclead
Study Sites (1)
University Medical Center of HCMC
Ho Chi Minh City, 700000, Vietnam
Related Publications (1)
Kawaida H, Kono H, Hosomura N, Amemiya H, Itakura J, Fujii H, Ichikawa D. Surgical techniques and postoperative management to prevent postoperative pancreatic fistula after pancreatic surgery. World J Gastroenterol. 2019 Jul 28;25(28):3722-3737. doi: 10.3748/wjg.v25.i28.3722.
PMID: 31391768BACKGROUND
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Truong Quoc Vo
University of Medicine and Pharmacy at HoChiMinh City
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 90 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Doctor, Lecturer, Surgeon
Study Record Dates
First Submitted
August 6, 2021
First Posted
August 23, 2021
Study Start
August 1, 2021
Primary Completion
October 31, 2023
Study Completion
October 31, 2023
Last Updated
May 17, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share
The IDP will be saved as excel and spss file